Publications by authors named "Gail D Lewis"

Claim this Profile
O
On Demand Bioorthogonal Switching of an Antibody-Conjugated SPECT Probe to a Cytotoxic Payload: from Imaging to Therapy.
Pragya Adhikari, Guangmin Li, MaryAnn Go, Danielle Mandikian, Hanine Rafidi, Gail D Lewis

J Am Chem Soc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.
Susan M Clardy, Alex Uttard, Bingfan Du, Kalli C Catcott, Kelly L Lancaster, Gail D Lewis

Mol Cancer Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.
Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.
Carsten Denkert, Chiara Lambertini, Peter A Fasching, Katherine L Pogue-Geile, Max S Mano, Gail D Lewis

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
Sanne L de Haas, Dennis J Slamon, Miguel Martin, Michael F Press, Gail D Lewis

Breast Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRC15 myofibroblasts dictate the stromal setpoint to suppress tumour immunity.
Akshay T Krishnamurty, Justin A Shyer, Minh Thai, Vineela Gandham, Matthew B Buechler, Gail D Lewis

Nature· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.
David B Agus, Robert W Akita, William D Fox, Gail D Lewis, Brian Higgins

Cancer Cell· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis